Eveline Hogenkamp-van Velp

Neurophyxia BV develops 2-iminobiotin novel injectable pharmaceutical products. Its pharmaceutical products reduce the deleterious effects of oxygen shortage in the brain occurring in two life threatening conditions: Cardiac arrest and Birth asphyxia. The company was founded by Paul Willem Theresia Josef Leufkens, Cacha Peeters-Scholte and Huibert Tjabbes in 2008 and is headquartered in 's-Hertogenbosch, the Netherlands.

Dutch Life Sciences Coöperatie UA is a company based in 's-Hertogenbosch, Netherlands. The company provides services to Dutch family offices by onboarding skills in the field of business, intellectual property, finance, and marketing and communication. The company collaborates with specialists to accelerate life sciences and make a difference. The company uses cookies to enhance the user experience on their website and also uses content and scripts from third parties. Eveline Hogenkamp-van Velp has been the CEO of the company since 2019.

Helvoet Rubber & Plastic Technologies BV designs, develops and manufactures of technical precision parts in rubber and plastic, rubber-metal and rubber-plastic bondings as well as assemblies combining rubber, plastic and metals. The company was founded in 1939 and is headquartered in Hellevoetsluis, the Netherlands.